CH644105A5 - Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere. - Google Patents

Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere. Download PDF

Info

Publication number
CH644105A5
CH644105A5 CH234080A CH234080A CH644105A5 CH 644105 A5 CH644105 A5 CH 644105A5 CH 234080 A CH234080 A CH 234080A CH 234080 A CH234080 A CH 234080A CH 644105 A5 CH644105 A5 CH 644105A5
Authority
CH
Switzerland
Prior art keywords
amino
quinolinecarboxylate
ethyl
methoxy
hydrochloride
Prior art date
Application number
CH234080A
Other languages
English (en)
French (fr)
Inventor
Harry Randall Jun Munson
Reevis Stancil Alphin
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of CH644105A5 publication Critical patent/CH644105A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH234080A 1979-03-26 1980-03-25 Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere. CH644105A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2398179A 1979-03-26 1979-03-26
US06/127,153 US4343804A (en) 1979-03-26 1980-03-04 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds

Publications (1)

Publication Number Publication Date
CH644105A5 true CH644105A5 (fr) 1984-07-13

Family

ID=26697875

Family Applications (1)

Application Number Title Priority Date Filing Date
CH234080A CH644105A5 (fr) 1979-03-26 1980-03-25 Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere.

Country Status (31)

Country Link
US (1) US4343804A (en, 2012)
JP (1) JPH02117663A (en, 2012)
AR (1) AR230268A1 (en, 2012)
AT (1) AT372373B (en, 2012)
AU (1) AU528388B2 (en, 2012)
BR (1) BR8001779A (en, 2012)
CA (1) CA1147338A (en, 2012)
CH (1) CH644105A5 (en, 2012)
DE (1) DE3011490A1 (en, 2012)
DK (1) DK156056C (en, 2012)
EG (1) EG15009A (en, 2012)
ES (1) ES8103048A1 (en, 2012)
FI (1) FI77452C (en, 2012)
FR (1) FR2452485B1 (en, 2012)
GB (1) GB2047244B (en, 2012)
GR (1) GR68006B (en, 2012)
HK (1) HK67983A (en, 2012)
IE (1) IE49577B1 (en, 2012)
IL (1) IL59628A (en, 2012)
IN (1) IN151446B (en, 2012)
IT (1) IT1133079B (en, 2012)
MX (1) MX6264E (en, 2012)
NL (1) NL8001752A (en, 2012)
NO (1) NO153927C (en, 2012)
NZ (1) NZ193252A (en, 2012)
PH (1) PH16416A (en, 2012)
PL (1) PL125030B1 (en, 2012)
PT (1) PT71008B (en, 2012)
SE (1) SE435837B (en, 2012)
SG (1) SG33683G (en, 2012)
YU (1) YU41702B (en, 2012)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804444D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804446D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804445D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5432182A (en) * 1989-02-23 1995-07-11 Smithkline Beecham Intercredit B.V. Compounds substituted quinoline derivatives
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
DE3917233A1 (de) * 1989-05-26 1990-11-29 Basf Ag 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel
GB8918265D0 (en) * 1989-08-10 1989-09-20 Smithkline Beckman Intercredit Compounds
US5362743A (en) * 1993-03-09 1994-11-08 Pfizer Inc. Aminoquinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
AU682051B2 (en) * 1993-08-10 1997-09-18 James Black Foundation Limited Gastrin and CCK receptor ligands
US5650415A (en) * 1995-06-07 1997-07-22 Sugen, Inc. Quinoline compounds
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
US5760041A (en) * 1996-02-05 1998-06-02 American Cyanamid Company 4-aminoquinazoline EGFR Inhibitors
US6875769B2 (en) * 1996-05-23 2005-04-05 Pfizer Inc. Substituted6,6-hetero-bicyclicderivatives
US5929080A (en) * 1997-05-06 1999-07-27 American Cyanamid Company Method of treating polycystic kidney disease
US6251912B1 (en) 1997-08-01 2001-06-26 American Cyanamid Company Substituted quinazoline derivatives
US6323209B1 (en) 1997-11-06 2001-11-27 American Cyanamid Company Method of treating or inhibiting colonic polyps
CA2344168C (en) 1998-09-29 2011-04-05 American Cyanamid Company Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
ES2246922T3 (es) * 1999-12-28 2006-03-01 Eisai Co., Ltd. Compuestos heterociclicos que tienen grupos de sulfonamida.
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
HRP20050696B1 (en) 2003-01-14 2008-10-31 Arena Pharmaceuticals Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
WO2004080967A1 (en) 2003-03-10 2004-09-23 Altana Pharma Ag Novel process for the preparation of roflumilast
BRPI0412689A (pt) * 2003-07-14 2006-10-03 Arena Pharm Inc derivados de heteroarila e arila fundida como moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a ele
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
WO2011022216A1 (en) * 2009-08-17 2011-02-24 High Point Pharmaceuticals, Llc Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
CA2786994C (en) 2010-01-27 2018-01-16 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
EP4445956A3 (en) 2015-01-06 2024-12-04 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
PT3310760T (pt) 2015-06-22 2022-11-10 Arena Pharm Inc Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1
US10889573B2 (en) * 2016-11-11 2021-01-12 Bayer Animal Health Gmbh Anthelmintic quinoline-3-carboxamide derivatives
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
WO2019084271A1 (en) * 2017-10-25 2019-05-02 Children's Medical Center Corporation PAPD5 INHIBITORS AND METHODS OF USE
SG11202010024UA (en) 2018-05-09 2020-11-27 Bayer Animal Health Gmbh New quinoline derivatives
KR20210029190A (ko) 2018-06-06 2021-03-15 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 병태의 치료 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
JPS4838712A (en, 2012) * 1971-09-18 1973-06-07

Also Published As

Publication number Publication date
JPH02117663A (ja) 1990-05-02
YU41702B (en) 1987-12-31
PL125030B1 (en) 1983-03-31
PL222993A1 (en, 2012) 1981-01-30
ES489887A0 (es) 1981-02-16
NZ193252A (en) 1984-04-27
NO800858L (no) 1980-09-29
NO153927C (no) 1986-06-18
ES8103048A1 (es) 1981-02-16
IL59628A (en) 1983-06-15
BR8001779A (pt) 1980-11-18
YU84480A (en) 1983-10-31
US4343804A (en) 1982-08-10
DK128380A (da) 1980-09-27
NO153927B (no) 1986-03-10
DK156056B (da) 1989-06-19
AU528388B2 (en) 1983-04-28
SE8002292L (sv) 1980-09-27
FR2452485B1 (fr) 1986-09-12
CA1147338A (en) 1983-05-31
FI77452C (fi) 1989-03-10
GB2047244A (en) 1980-11-26
IT8067465A0 (it) 1980-03-26
PH16416A (en) 1983-09-29
AU5684880A (en) 1980-10-02
IN151446B (en, 2012) 1983-04-23
SG33683G (en) 1985-03-29
FI77452B (fi) 1988-11-30
ATA156480A (de) 1983-02-15
MX6264E (es) 1985-02-19
FR2452485A1 (fr) 1980-10-24
GR68006B (en, 2012) 1981-10-26
FI800910A7 (fi) 1980-09-27
PT71008B (en) 1981-06-25
IE49577B1 (en) 1985-10-30
NL8001752A (nl) 1980-09-30
HK67983A (en) 1983-12-23
IL59628A0 (en) 1980-06-30
SE435837B (sv) 1984-10-22
IT1133079B (it) 1986-07-09
EG15009A (en) 1985-03-31
GB2047244B (en) 1983-02-23
PT71008A (en) 1980-04-01
DE3011490C2 (en, 2012) 1988-12-22
AT372373B (de) 1983-09-26
DE3011490A1 (de) 1981-03-12
IE800605L (en) 1980-09-26
DK156056C (da) 1989-11-06
AR230268A1 (es) 1984-03-01

Similar Documents

Publication Publication Date Title
CH644105A5 (fr) Acides et esters 4-amino-3-quinoleinecarboxyliques, utiles notamment comme agent antisecretoires et anti-ulcere.
US4670566A (en) 3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
DE69524114T2 (de) Naphthyridinonderivate
US4440785A (en) Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation
CY1201A (en) Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents
JPH06220026A (ja) 置換シクロプロピルアミノ−１，３，５−トリアジン化合物
HU217623B (hu) Eljárás kondenzált tieno- és pirrolo [3,2-c]piridin-2-karbonsav-származékok valamint e vegyületeket tartalmazó gyógyászati készítmények előállítására
US5679677A (en) Heterocyclic carbamates, process for their preparation and medicaments
JPS6136282A (ja) 窒素を含む複素環式化合物からなる医薬品とその製造方法
CH630085A5 (fr) Nouvelles imidazoquinoleines et leurs sels, procede de preparation et compositions pharmaceutiques.
EP0076199B1 (fr) Nouvelles triazoloquinazolones et leurs sels, procédé et intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
FR2593818A1 (fr) Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
DE4141218A1 (de) Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
FR2476071A1 (fr) Nouveaux acides 2-amino-3-(a-hydroxybenzyl)-phenylacetiques et leurs esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant
CH659469A5 (fr) Derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation et les medicaments et compositions les renfermant.
JPS6399057A (ja) グリシン誘導体
EP0034529B1 (fr) Nouveaux dérivés de la triazoloquinazolinone et leurs sels avec les acides, leur préparation, leur application comme médicaments, et les compositions les renfermant
CA1051436A (en) 4-amino-amphetamine derivatives
CS217997B2 (en) Method of making the new derivatives of the pyrimidine
DE2233682A1 (de) 2- eckige klammer auf 3-(subst. aminomethyl)-4-h-1,2,4-triazol-4-yl eckige klammer zu -benzophenone, ein verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
EP0305298A2 (fr) Nouvelles imidazo benzodiazépines et leurs sels d'addition avec les acides, leur procédé et les intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
CS228531B2 (en) Method for the production of phenylpiperazine derivates
CH645357A5 (fr) Imino-2-imidazolidines 4-substituees utiles en therapie et des medicaments les contenant.
CA1207768A (fr) Carboxamidoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1161757A (en) 4-amino-3-quinolinecarboxylic acids and esters- antisecretory, anti-ulcer compounds

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased